FK506: mechanism of immunosuppression and adverse-effects.
Research Laboratories, Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan.
K
K
Tamura
D000818:Animals; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007108:Immune Tolerance / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects; D051381:Rats; D016559:Tacrolimus / Q000009:adverse effects / Q000494:pharmacology*
D007166:Immunosuppressive Agents; D016559:Tacrolimus